Gene therapy offers HD patients relief from some symptoms. Tetrabenazine inhibits the transport of a molecule called vesicular monoamine transporter type 2 or VMAT2.
Morrow
Thomas
T
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015316:Genetic Therapy; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy* / Q000503:physiopathology; D013747:Tetrabenazine / Q000494:pharmacology* / Q000627:therapeutic use; D050493:Vesicular Monoamine Transport Proteins / Q000187:drug effects*
D018759:Adrenergic Uptake Inhibitors; D050493:Vesicular Monoamine Transport Proteins; D013747:Tetrabenazine